{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:56:59Z","timestamp":1792205819863,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jhep.2020.04.036","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:19:38Z","timestamp":1588540778000},"page":"651-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults"],"prefix":"10.1016","volume":"73","author":[{"given":"Albert Friedrich","family":"St\u00e4ttermayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Halilbasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Wrba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ferenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.04.036_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jhep.2015.02.025","article-title":"Genetics of liver disease: from pathophysiology to clinical practice","volume":"62","author":"Karlsen","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1809315","article-title":"Genetic variation, comparative genomics and the diagnosis of disease","volume":"381","author":"Eichler","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.04.036_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1969.02100030114014","article-title":"Byler disease: fatal intrahepatic cholestasis in an Amish kindred","volume":"117","author":"Clayton","year":"1969","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jhep.2020.04.036_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.510260121","article-title":"Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity","volume":"1","author":"Bull","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng0398-219","article-title":"A\u00a0gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis","volume":"18","author":"Bull","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2020.04.036_bib7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.04.036_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Srivastava","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"suppl 1","key":"10.1016\/j.jhep.2020.04.036_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0030-1253221","article-title":"Progressive familial intrahepatic cholestasis type 1","volume":"30","author":"Paulusma","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/515501","article-title":"Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24","volume":"61","author":"Strautnieks","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2020.04.036_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0378-1119(88)90057-1","article-title":"Sequence of mdr3 cDNA encoding a human p-glycoprotein","volume":"71","author":"van der Bliek","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.jhep.2020.04.036_bib13","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.dld.2019.04.013","article-title":"Familial intrahepatic cholestasis: new and wide perspectives","volume":"51","author":"Vitale","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib14","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.04.036_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.28779","article-title":"MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease","volume":"65","author":"Gonzalez","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","article-title":"Function and pathophysiological importance of ABCB4 (MDR3 P -glycoprotein)","volume":"453","author":"Oude Elferink","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jhep.2020.04.036_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2020.04.036_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00008571-200402000-00003","article-title":"Sequence analysis of bile salt export pump (ABCB11) and multi drug resistance p-glycoprotein 2 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy","volume":"14","author":"Pauli-Magnus","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jhep.2020.04.036_bib19","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2001.23947","article-title":"MDR3 gene defects in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis","volume":"120","author":"Rosmorduc","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jhep.2020.04.036_bib21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A\u00a0mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthard","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis in adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.3247","article-title":"Large-scale whole genome sequencing of the Icelandic population","volume":"47","author":"Gudbjartsson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2020.04.036_bib25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.clinre.2015.08.004","article-title":"A\u00a0letter on ABCB4 from Iceland: on the highway to liver disease","volume":"39","author":"Lammert","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(94)01135-4","article-title":"The human MDR3 p-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice","volume":"354","author":"Smit","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2020.04.036_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bse0500043","article-title":"Structure of ABC transporters","volume":"50","author":"Zolnerciks","year":"2011","journal-title":"Essays Biochem"},{"key":"10.1016\/j.jhep.2020.04.036_bib28","first-page":"17","article-title":"Bile acid secretion, bile flow and biliary lipid secretion in humans","volume":"12","author":"Hofmann","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"De Vree","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2020.04.036_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.21500","article-title":"Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy","volume":"45","author":"Schneider","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28300","article-title":"A\u00a0functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3","volume":"63","author":"Delaunay","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.2004.062786","article-title":"Patterns of GI disease in adulthood associated with mutations in the CFTR gene","volume":"56","author":"Wilschanski","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.04.036_bib33","first-page":"728","article-title":"Cholestatic liver disease from child to adult: the diversity of MDR3 disease","volume":"49","author":"Kubitz","year":"2011","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0038-1667299","article-title":"ABCB4 gene aberrations in human liver disease: an evolving spectrum","volume":"38","author":"Reichert","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations","volume":"52","author":"Colombo","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2020.04.036_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1149","article-title":"Phenotypic spectrum and diagnostic pitfall of ABCB4 deficiency depending on age of onset","volume":"2","author":"Schatz","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2020.04.036_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0168-8278(03)00049-7","article-title":"Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills","volume":"38","author":"Ganne-Carri\u00e9","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0016-5085(03)00898-9","article-title":"ABCB4 gene mutation-associated cholelithiasis in adults","volume":"125","author":"Rosmorduc","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"29","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib42","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.dld.2013.04.002","article-title":"Prevalence of low phospholipid-associated cholelithiasis in young female patients","volume":"45","author":"Condat","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0030-1253224","article-title":"Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy","volume":"30","author":"Pauli-Magnus","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib44","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clinre.2010.11.011","article-title":"Liver diseases unique to pregnancy: a 2010 update","volume":"35","author":"Bacq","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinre.2015.12.008","article-title":"The pathophysiology of intrahepatic cholestasis of pregnancy","volume":"40","author":"Dixon","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(05)77221-4","article-title":"Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy","volume":"353","author":"Jacquemin","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.04.036_bib48","first-page":"1327","article-title":"Intrahepatic cholestasis of pregnancy (ICP): case report and review of literature","volume":"54","author":"Keitel","year":"2016","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.04.036_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.21111","article-title":"Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study","volume":"43","author":"Ropponen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jhep.2015.03.010","article-title":"Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study","volume":"63","author":"Wikstr\u00f6m Shemer","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2015.11.030","article-title":"Pregnancy and liver disease","volume":"64","author":"Westbrook","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib53","doi-asserted-by":"crossref","first-page":"23530","DOI":"10.1074\/jbc.M909002199","article-title":"MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping","volume":"275","author":"Smith","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2020.04.036_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000365003","article-title":"Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury","volume":"90","author":"Zollner","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2020.04.036_bib55","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"Drug-induced liver injury","volume":"70","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0009922812451076","article-title":"Progressive familial intrahepatic cholestasis type 3: overlapping presentation with Wilson disease","volume":"51","author":"Ramraj","year":"2012","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jhep.2020.04.036_bib58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10354-008-0592-1","article-title":"Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases","volume":"158","author":"Trauner","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jhep.2020.04.036_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0031-1272831","article-title":"Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings","volume":"31","author":"Morotti","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.04.036_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-012-1202-6","article-title":"Aspects of liver pathology in adult patients with MDR3\/ABCB4 gene mutations","volume":"460","author":"Wendum","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhep.2020.04.036_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2006.10.034","article-title":"Novel resequencing chip to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis","volume":"132","author":"Liu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00365521.2017.1422800","article-title":"Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination","volume":"53","author":"Aamann","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib63","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","article-title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants","volume":"67","author":"Dr\u00f6ge","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","article-title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing","volume":"53","author":"Vitale","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib65","series-title":"Liver Disease in Children","first-page":"195","article-title":"Medical and nutritional management of cholestasis","author":"Feranchak","year":"2001"},{"key":"10.1016\/j.jhep.2020.04.036_bib66","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10354-008-0594-z","article-title":"Cholestasis and metabolic bone disease - a clinical review","volume":"158","author":"Gasser","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jhep.2020.04.036_bib67","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12072-014-9548-2","article-title":"Vitamin D modulates biliary fibrosis in ABCB4-deficient mice","volume":"8","author":"Hochrath","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2020.04.036_bib68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2015.02.074","article-title":"1,25-(OH)\u2082-vitamin D\u2083 prevents activation of hepatic stellate cells in\u00a0vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-\/-) model","volume":"459","author":"Reiter","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2020.04.036_bib69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bone.2013.03.012","article-title":"Modeling hepatic osteodystrophy in Abcb4 deficient mice","volume":"55","author":"Hochrath","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jhep.2020.04.036_bib70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2005.01000.x","article-title":"Intrahepatic cholestasis of pregnancy: from bedside to bench to bedside","volume":"25","author":"Poupon","year":"2005","journal-title":"Liv Int"},{"key":"10.1016\/j.jhep.2020.04.036_bib71","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib72","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanism of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib74","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1053\/j.gastro.2012.08.004","article-title":"Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis","volume":"143","author":"Bacq","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.04.036_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.04.036_bib76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jhep.2019.11.018","article-title":"Reply to: \u201cUDCA therapy in intrahepatic cholestasis of pregnancy?\u201d","volume":"72","author":"Beuers","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2015.03.020","article-title":"Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy","volume":"189","author":"Geenes","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jhep.2020.04.036_bib78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0000000000000056","article-title":"Fibrate treatment for primary biliary cirrhosis","volume":"30","author":"Cuperus","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2020.04.036_bib79","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A\u00a0placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.04.036_bib80","first-page":"S1","article-title":"Bezafibrate is more effective then placebo in pruritus of chronic cholestasis: the FITCH trial","volume":"70","author":"De Vries","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1872-034X.2007.00069.x","article-title":"Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice","volume":"37","author":"Shoda","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2020.04.036_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/CPP48022","article-title":"Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway","volume":"48","author":"Nakamuta","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.04.036_bib83","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor \u03b1 activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib84","doi-asserted-by":"crossref","first-page":"51085","DOI":"10.1074\/jbc.M308321200","article-title":"Farnesoid X receptor activates transcription of the phospholipid pump MDR3","volume":"278","author":"Huang","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2020.04.036_bib85","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.04.036_bib86","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2016.01.016","article-title":"Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid","volume":"64","author":"Ijssennagger","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.04.036_bib87","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2-\/- (Abcb4-\/-) mouse cholangiopathy model by promoting biliary HCO\u207b\u2083 output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib88","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1194\/jlr.M084145","article-title":"Thyroid hormone receptor \u03b21 stimulates ABCB4 to increase biliary phosphatidylcholine excretion in mice","volume":"59","author":"Gautherot","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2020.04.036_bib89","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.21630","article-title":"4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps","volume":"45","author":"Hayashi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib90","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.23209","article-title":"Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin","volume":"50","author":"van den Berghe","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib91","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/hep.23268","article-title":"Folding defects in P-type ATP8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate","volume":"51","author":"van der Velden","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2020.04.036_bib92","doi-asserted-by":"crossref","first-page":"e0150098","DOI":"10.1371\/journal.pone.0150098","article-title":"Functional rescue of trafficking-impaired ABCB4 mutants by chemical chaperons","volume":"11","author":"Gordo-Gilart","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.04.036_bib93","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.27767","article-title":"Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: evidence for improvement of cholestasis with 4-phenylbutyrate","volume":"62","author":"Gonzales","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib95","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1038\/s41598-019-53628-x","article-title":"Effect of\u00a0food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis","volume":"9","author":"Nakano","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.04.036_bib96","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.28929","article-title":"Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770)","volume":"65","author":"Delaunay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.04.036_bib97","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1038\/s41598-019-43111-y","article-title":"Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models","volume":"9","author":"Vauthier","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.04.036_bib98","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.tp.0000282869.94152.4f","article-title":"Liver transplantation in children with progressive familial intrahepatic cholestasis","volume":"84","author":"Englert","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2020.04.036_bib99","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1399-0012.2010.01368.x","article-title":"Progressive familial intrahepatic cholestasis: a single-centre experience of living-donor liver transplantation during two decades in Japan","volume":"25","author":"Hori","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2020.04.036_bib100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S2210-7401(12)70019-0","article-title":"Low phospholipid-associated cholestasis and cholelithiasis","volume":"36","author":"Erlinger","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820302804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820302804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:39:53Z","timestamp":1759174793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820302804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0168827820302804"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.04.036","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}